Free Trial

Definitive Healthcare's (DH) Sell (D-) Rating Reaffirmed at Weiss Ratings

Definitive Healthcare logo with Computer and Technology background

Key Points

  • Definitive Healthcare's stock has been reaffirmed with a "sell (D-)" rating by Weiss Ratings, indicating a bearish outlook on the company.
  • Despite the downgrade, some analysts have raised their target prices for the stock, with Stifel Nicolaus increasing it to $6.00 and maintaining a "buy" rating.
  • Institutional investors have significantly increased their stakes in the company, with notable transactions including a 424.2% increase by the State of Wyoming in the 2nd quarter.
  • Five stocks we like better than Definitive Healthcare.

Definitive Healthcare (NASDAQ:DH - Get Free Report)'s stock had its "sell (d-)" rating reissued by Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

Several other research firms have also recently issued reports on DH. Stifel Nicolaus boosted their target price on Definitive Healthcare from $5.00 to $6.00 and gave the company a "buy" rating in a research note on Friday, August 8th. Wall Street Zen raised Definitive Healthcare from a "hold" rating to a "buy" rating in a report on Saturday, June 21st. Finally, Robert W. Baird set a $4.00 target price on Definitive Healthcare in a report on Friday, August 8th. One analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the stock has an average rating of "Reduce" and a consensus target price of $4.28.

View Our Latest Report on DH

Definitive Healthcare Price Performance

NASDAQ:DH traded up $0.04 during mid-day trading on Wednesday, reaching $3.23. The stock had a trading volume of 272,480 shares, compared to its average volume of 355,270. The firm has a 50 day moving average price of $3.89 and a two-hundred day moving average price of $3.52. The stock has a market capitalization of $462.35 million, a P/E ratio of -1.22 and a beta of 1.65. Definitive Healthcare has a one year low of $2.15 and a one year high of $5.68. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.65 and a current ratio of 1.65.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently made changes to their positions in DH. State of Wyoming grew its stake in Definitive Healthcare by 424.2% during the 2nd quarter. State of Wyoming now owns 133,647 shares of the company's stock worth $521,000 after buying an additional 108,154 shares during the last quarter. Caxton Associates LLP acquired a new position in shares of Definitive Healthcare in the 2nd quarter valued at about $308,000. Tower Research Capital LLC TRC raised its holdings in Definitive Healthcare by 357.5% in the 2nd quarter. Tower Research Capital LLC TRC now owns 17,233 shares of the company's stock worth $67,000 after purchasing an additional 13,466 shares during the period. Engineers Gate Manager LP acquired a new position in Definitive Healthcare in the 2nd quarter worth about $292,000. Finally, Brevan Howard Capital Management LP increased its stake in Definitive Healthcare by 635.0% during the 2nd quarter. Brevan Howard Capital Management LP now owns 112,124 shares of the company's stock worth $437,000 after buying an additional 96,869 shares in the last quarter. 98.67% of the stock is currently owned by hedge funds and other institutional investors.

Definitive Healthcare Company Profile

(Get Free Report)

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.

Recommended Stories

Analyst Recommendations for Definitive Healthcare (NASDAQ:DH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Definitive Healthcare Right Now?

Before you consider Definitive Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Definitive Healthcare wasn't on the list.

While Definitive Healthcare currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.